Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
Saved in:
| Title: | Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. |
|---|---|
| Authors: | Dorst DN; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Smeets EMM; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Klein C; Roche Pharma Research and Early Development, Innovation Center Zurich, 8952 Schlieren, Switzerland., Frielink C; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Geijs D; Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Trajkovic-Arsic M; Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany.; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany., Cheung PFY; Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany.; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany., Stommel MWJ; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Siveke JT; Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany.; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany., Aarntzen EHJG; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Lith SAM; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. |
| Source: | Molecular pharmaceutics [Mol Pharm] 2023 Aug 07; Vol. 20 (8), pp. 4319-4330. Date of Electronic Publication: 2023 Jul 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37485886 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dorst+DN%22">Dorst DN</searchLink>; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Smeets+EMM%22">Smeets EMM</searchLink>; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Klein+C%22">Klein C</searchLink>; Roche Pharma Research and Early Development, Innovation Center Zurich, 8952 Schlieren, Switzerland.<br /><searchLink fieldCode="AU" term="%22Frielink+C%22">Frielink C</searchLink>; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Geijs+D%22">Geijs D</searchLink>; Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Trajkovic-Arsic+M%22">Trajkovic-Arsic M</searchLink>; Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany.; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Cheung+PFY%22">Cheung PFY</searchLink>; Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany.; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Stommel+MWJ%22">Stommel MWJ</searchLink>; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gotthardt+M%22">Gotthardt M</searchLink>; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Siveke+JT%22">Siveke JT</searchLink>; Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany.; Division of Solid Tumour Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Aarntzen+EHJG%22">Aarntzen EHJG</searchLink>; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Lith+SAM%22">van Lith SAM</searchLink>; Department of Medical Imaging, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101197791%22">Molecular pharmaceutics</searchLink> [Mol Pharm] 2023 Aug 07; Vol. 20 (8), pp. 4319-4330. <i>Date of Electronic Publication: </i>2023 Jul 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101197791 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-8392 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215438384%22">15438384 </searchLink><i>NLM ISO Abbreviation: </i>Mol Pharm <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37485886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acs.molpharmaceut.3c00453 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4319 Titles: – TitleFull: Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dorst DN – PersonEntity: Name: NameFull: Smeets EMM – PersonEntity: Name: NameFull: Klein C – PersonEntity: Name: NameFull: Frielink C – PersonEntity: Name: NameFull: Geijs D – PersonEntity: Name: NameFull: Trajkovic-Arsic M – PersonEntity: Name: NameFull: Cheung PFY – PersonEntity: Name: NameFull: Stommel MWJ – PersonEntity: Name: NameFull: Gotthardt M – PersonEntity: Name: NameFull: Siveke JT – PersonEntity: Name: NameFull: Aarntzen EHJG – PersonEntity: Name: NameFull: van Lith SAM IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 08 Text: 2023 Aug 07 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1543-8392 Numbering: – Type: volume Value: 20 – Type: issue Value: 8 Titles: – TitleFull: Molecular pharmaceutics Type: main |
| ResultId | 1 |